Competition Law and Health Infrastructure Competition Policy

1. Introduction

Health infrastructure competition policy concerns the application of competition law to the markets and infrastructure through which healthcare services are produced, distributed, financed and accessed.

Health infrastructure extends well beyond hospitals. It may include:

hospitals and hospital networks;

diagnostic laboratories;

pharmacies;

medical-device infrastructure;

pharmaceutical distribution;

health-information systems;

electronic health records;

telemedicine platforms;

ambulance networks;

health insurance networks;

medical procurement systems;

healthcare logistics and cold chains;

specialist facilities;

medical imaging infrastructure; and

digital health platforms.

Competition policy in healthcare presents a distinctive challenge. Healthcare markets contain ordinary competitive forces, but they also involve patient welfare, professional regulation, information asymmetry, public funding, licensing restrictions and essential infrastructure.

The objective of competition law is therefore not simply to force prices downward. It is to preserve effective competition while allowing legitimate healthcare regulation, quality standards, safety requirements and investment in infrastructure.

2. Meaning of Health Infrastructure Competition Policy

Health infrastructure competition policy can be understood as the framework used to ensure that control over essential healthcare infrastructure does not unnecessarily restrict competition.

It addresses three broad questions:

A. Who controls infrastructure?

For example:

one hospital network;

one diagnostic chain;

one health-data platform;

one insurer-provider network.

B. Who can access it?

For example:

competing doctors;

laboratories;

pharmacies;

insurers;

medical-device companies;

independent hospitals.

C. On what conditions?

Access may be:

open;

exclusive;

discriminatory;

excessively priced;

technologically restricted;

contractually restricted.

3. Why Healthcare Infrastructure Requires Special Competition Analysis

Healthcare infrastructure has several characteristics that distinguish it from ordinary commercial markets.

High entry costs

Hospitals and laboratories require:

land;

equipment;

trained professionals;

regulatory approvals;

accreditation;

capital.

Network effects

Digital health systems become more valuable as more:

patients;

doctors;

hospitals;

insurers

join the system.

Information asymmetry

Patients often cannot assess quality as easily as ordinary consumers can assess products.

Geographic constraints

A hospital may possess substantial market power in a particular geographic area even where the national healthcare market is competitive.

Switching costs

Patients and doctors may face significant costs in moving:

medical records;

insurance coverage;

diagnostic history;

electronic health records;

treatment relationships.

4. Relevant Markets in Healthcare

Market definition is fundamental.

A competition authority may need to distinguish between:

general hospitals;

specialist hospitals;

emergency care;

maternity services;

cardiac services;

diagnostic laboratories;

imaging services;

pharmaceutical distribution;

health insurance;

digital health platforms.

Geographic markets may be:

local;

regional;

national;

international.

For example, a hospital merger cannot necessarily be assessed solely by looking at national market shares because patients may not realistically travel hundreds of kilometres for routine medical care.

5. Horizontal Concentration in Hospitals

Hospital mergers can produce significant concentration.

Suppose:

Hospital A + Hospital B → Hospital Network

If both hospitals previously competed for patients, doctors and insurers, the merger may eliminate an important competitive constraint.

Potential effects include:

higher prices;

reduced insurer bargaining power;

lower quality;

reduced investment;

fewer choices for patients;

reduced physician competition.

However, consolidation can also create efficiencies such as:

integrated specialist services;

better equipment utilization;

shared emergency facilities;

improved patient coordination;

reduced administrative costs.

Competition policy therefore requires an effects-based assessment.

6. Hospital Buying Power

Competition policy must also consider buy-side concentration.

Hospitals may purchase:

medical devices;

pharmaceuticals;

laboratory supplies;

surgical equipment;

hospital software;

medical services.

If several hospitals coordinate purchasing, they may possess significant buyer power.

Purchasing cooperation can reduce costs.

But competing hospitals coordinating strategically sensitive procurement information may reduce competition among buyers.

Thus:

Buyer power can produce efficiencies, but coordinated buyer conduct can also become anticompetitive.

7. Physician Markets

Hospitals may compete not only for patients but also for physicians.

Competition concerns may arise from:

non-compete clauses;

exclusivity agreements;

restrictive employment arrangements;

coordinated physician compensation;

restrictions on physicians working across competing hospitals.

These issues have become increasingly important as competition law examines labour-market competition and monopsony.

A hospital network with substantial purchasing power over medical labour could potentially reduce competition for physicians.

8. Health Insurance and Provider Networks

Healthcare frequently involves a three-sided relationship:

Patient ↔ Insurer ↔ Healthcare Provider

Insurance companies may negotiate prices and network participation with hospitals.

Competition concerns may arise where insurers:

exclude competing providers;

impose exclusivity;

use discriminatory reimbursement arrangements;

merge with hospitals;

restrict access to competing facilities.

Vertical integration between insurers and healthcare providers can produce efficiencies but may also create foreclosure risks.

9. Vertical Integration

Consider:

Insurance company + Hospital network

The integrated firm could potentially favour its own hospitals over competing hospitals.

Alternatively:

Hospital + Diagnostic laboratory

The hospital could require patients to use its own laboratory.

Or:

Digital health platform + Pharmacy

The platform could give preferential access to its own pharmacy.

Competition law therefore needs to consider:

input foreclosure;

customer foreclosure;

tying;

bundling;

self-preferencing;

discriminatory access.

10. Essential Facilities and Healthcare Infrastructure

Some healthcare infrastructure can be extremely difficult to duplicate.

Examples may include:

specialized diagnostic facilities;

unique medical databases;

particular emergency infrastructure;

specialized laboratory networks;

interoperable health-information systems.

This raises the question of whether a dominant undertaking must provide competitors access.

The essential-facilities doctrine, however, is applied cautiously.

Competition law does not ordinarily require a firm to share every asset with competitors.

The refusal must satisfy the demanding legal conditions associated with abusive refusal to supply.

11. Bronner and Healthcare Infrastructure

Oscar Bronner GmbH & Co. KG v Mediaprint

Case C-7/97

Bronner is a leading European authority on refusal to provide access to infrastructure.

The Court set a high threshold for requiring a dominant undertaking to grant access to infrastructure.

Healthcare significance

The principles can apply where a healthcare operator controls infrastructure that competitors seek to access.

A competition authority would need to consider questions such as:

Is the infrastructure genuinely indispensable?

Is duplication practically or economically impossible?

Would refusal eliminate effective competition?

Is there an objective justification?

This prevents competition law from becoming a general mechanism for compulsory sharing of infrastructure.

12. United Brands and Healthcare Market Power

United Brands v Commission

Case 27/76

United Brands remains important for understanding:

market definition;

dominance;

geographic market;

economic dependence.

Healthcare relevance

Suppose one hospital is the only realistic provider of a particular specialized service in a region.

The relevant geographic market might be considerably narrower than the national healthcare market.

The case therefore supports careful examination of:

patient travel;

alternatives;

transportation;

referral patterns;

specialized expertise.

13. MEO and Discriminatory Conditions

MEO — MEO – Serviços de Comunicações e Multimédia

Case C-525/16

The Court addressed discriminatory pricing under Article 102(c) TFEU.

The case is relevant to the assessment of whether differences in conditions imposed on trading partners can distort competition.

Healthcare relevance

A dominant healthcare infrastructure provider could potentially provide different access or pricing conditions to competing:

insurers;

hospitals;

laboratories;

medical providers.

The legal inquiry should focus on whether the discriminatory treatment places particular trading partners at a competitive disadvantage.

14. Slovak Telekom and Infrastructure Access

Slovak Telekom v Commission

Joined Cases C-152/19 P and C-165/19 P

The case involved access to telecommunications infrastructure and abusive exclusionary conduct.

Although telecommunications is not healthcare, the principles are highly relevant to modern health infrastructure because both sectors increasingly rely upon infrastructure networks.

Healthcare application

Comparable questions could arise concerning:

digital health platforms;

health-information infrastructure;

interoperability systems;

laboratory networks;

electronic medical-record platforms.

Where a dominant infrastructure provider restricts access to competing downstream providers, competition authorities may examine whether the conduct forecloses competition.

15. IMS Health and Health Data Infrastructure

IMS Health GmbH & Co. OHG v NDC Health GmbH & Co. KG

Case C-418/01

This case is especially relevant to healthcare.

It concerned access to a pharmaceutical sales-information structure and intellectual-property rights.

The Court addressed the exceptional circumstances in which refusal to license intellectual property could constitute abuse of dominance.

Importance

IMS Health illustrates the intersection of:

intellectual property;

data;

infrastructure;

market power;

interoperability.

Modern health infrastructure increasingly depends on data systems.

Examples include:

electronic health records;

pharmaceutical databases;

clinical datasets;

health analytics;

diagnostic databases.

The case demonstrates that competition law must balance infrastructure access against legitimate intellectual-property rights.

16. Microsoft and Interoperability

Microsoft Corp. v Commission

Case T-201/04

Microsoft is important for the relationship between dominance and interoperability.

The case involved restrictions affecting interoperability between Microsoft's systems and competing products.

Healthcare relevance

Interoperability is becoming fundamental to healthcare.

A dominant health-information platform might potentially control:

patient records;

APIs;

authentication;

clinical software;

hospital systems.

If competing healthcare providers cannot effectively interoperate with a dominant system, competition may be impaired.

Therefore, interoperability can itself become a competition-policy issue.

17. Google Android and Health Platforms

Google and Alphabet v Commission

Case T-604/18

The Android case concerned Google's conduct involving its mobile ecosystem.

Although not a healthcare case, its principles are relevant to digital health infrastructure.

Healthcare platforms increasingly integrate:

apps;

devices;

payments;

identity;

data;

pharmacies;

telemedicine.

A dominant ecosystem could potentially use control over one layer to disadvantage competitors operating at another layer.

This creates possible:

tying;

bundling;

self-preferencing;

interoperability;

exclusionary conduct

issues.

18. Hospital Mergers and Geographic Concentration

Hospital mergers require especially careful geographic analysis.

Suppose a city has:

Hospital A;

Hospital B;

Hospital C.

If A and B merge, the remaining Hospital C may become the only significant independent competitor.

The competition authority may examine:

patient catchment areas;

travel times;

emergency-service availability;

specialist capacity;

insurer contracts;

physician affiliations.

Thus, hospital competition is frequently local or regional rather than purely national.

19. Diagnostic Laboratory Concentration

Diagnostic markets present similar concerns.

Large diagnostic networks may benefit from:

centralized laboratories;

economies of scale;

brand recognition;

extensive collection centres;

insurance contracts;

digital booking systems.

Consolidation may create efficiencies.

But excessive concentration could make it difficult for independent laboratories to obtain:

hospital referrals;

insurance recognition;

collection access;

equipment;

specialist testing.

Competition authorities should therefore examine both horizontal concentration and vertical relationships.

20. Medical Device Infrastructure

Medical devices may involve specialized infrastructure such as:

MRI systems;

robotic surgical systems;

specialized implants;

diagnostic equipment.

Competition issues may arise through:

exclusive supply agreements;

tying equipment to consumables;

exclusive maintenance arrangements;

interoperability restrictions;

patent licensing;

aftermarket restrictions.

A supplier with dominance in primary equipment could potentially use that position to control related aftermarket services.

21. Tying in Healthcare

Consider:

Hospital software → mandatory diagnostic platform

or

Medical equipment → mandatory consumables

or

Health platform → mandatory payment service

Where a dominant firm conditions access to one product on acceptance of another, competition authorities may examine tying.

Microsoft demonstrates how technological integration can create competition concerns where control over one product is leveraged into another market.

22. Exclusive Agreements

Healthcare infrastructure may involve long-term exclusivity.

Examples:

hospital-exclusive laboratory contracts;

insurer-exclusive provider networks;

exclusive medical-device supply;

exclusive pharmacy arrangements;

exclusive health-platform agreements.

Exclusivity can encourage:

investment;

quality assurance;

equipment financing;

service integration.

But extensive exclusivity can foreclose rivals.

The key questions are:

Who imposed the exclusivity?

What is their market power?

How much of the market is covered?

How long does it last?

Can competitors realistically enter?

23. Digital Health Infrastructure

Digitalization introduces a new competition dimension.

Important infrastructure includes:

electronic health records;

cloud health systems;

telemedicine platforms;

health APIs;

health-data exchanges;

digital pharmacies;

appointment platforms;

AI diagnostic systems.

Potential competition concerns include:

Data concentration

One platform controls extensive patient or provider data.

Interoperability barriers

Rivals cannot easily connect.

Switching costs

Hospitals cannot easily move their records and systems.

Self-preferencing

The platform favours its own healthcare services.

Bundling

Access to one service requires use of another.

24. Health Data as a Competitive Resource

Health data can create competitive advantages.

A platform with large-scale data may improve:

diagnosis;

demand forecasting;

clinical decision support;

personalized treatment;

medical research.

Competition concerns arise where a dominant platform uses its data advantage to exclude competitors.

However, healthcare data is also heavily regulated for privacy and patient-protection reasons.

Competition policy therefore has to operate alongside:

data protection;

medical confidentiality;

cybersecurity;

health regulation.

25. Ambulance and Emergency Infrastructure

Emergency healthcare presents particularly sensitive competition issues.

Markets may involve:

ambulance operators;

emergency dispatch;

hospitals;

emergency transport networks.

A dominant dispatch system could potentially discriminate against rival providers.

Possible conduct includes:

preferential allocation;

discriminatory dispatch;

exclusive contracts;

denial of access;

discriminatory pricing.

Because emergency services may have significant geographic and time constraints, market definition requires particular care.

26. Pharmaceutical Distribution Infrastructure

Pharmaceutical distribution involves:

Manufacturer → Wholesaler → Pharmacy/Hospital → Patient

Competition concerns can arise through:

exclusive distribution;

territorial restrictions;

supply restrictions;

discriminatory allocation;

refusal to supply;

excessive concentration.

Where a medicine is essential and supply is limited, contractual restrictions may have particularly significant competitive consequences.

27. Procurement and Public Healthcare

Public hospitals frequently purchase:

medicines;

medical devices;

diagnostic services;

hospital equipment;

IT systems.

Competition problems may include:

bid rigging;

market allocation;

cover bidding;

procurement collusion;

specification manipulation.

Competition law and public procurement law therefore interact closely.

A public healthcare procurement system should ideally preserve:

competitive tendering;

transparent specifications;

independent bids;

equal access;

effective monitoring.

28. Indian Competition Act, 2002

The Indian framework is particularly relevant because healthcare markets are increasingly commercialized and technologically integrated.

Section 3

Section 3 addresses anticompetitive agreements.

Healthcare infrastructure agreements potentially covered include:

hospital coordination;

procurement cartels;

exclusive supply;

exclusive distribution;

refusal-to-deal arrangements;

tying arrangements;

resale-price maintenance.

Section 4

Section 4 prohibits abuse of dominant position.

Possible healthcare examples include:

discriminatory access;

unfair conditions;

exclusionary contracts;

denial of market access;

leveraging dominance from one healthcare market into another.

Sections 5 and 6

These provisions concern combinations.

Hospital and healthcare mergers can therefore be examined where statutory thresholds and other applicable conditions are satisfied.

29. Competition and Quality of Healthcare

A particularly important issue is that healthcare competition cannot be evaluated solely through price.

Competition can occur through:

treatment quality;

waiting time;

availability of specialists;

technological capability;

patient experience;

infection control;

emergency response;

innovation.

A merger that does not immediately increase prices could nevertheless weaken competition if it reduces incentives to improve quality.

Therefore:

Non-price competition is central to healthcare competition policy.

30. Efficiency Defences

Healthcare infrastructure can generate substantial efficiencies through scale.

For example, a hospital merger might permit:

shared MRI equipment;

centralized laboratories;

unified procurement;

specialist concentration;

improved emergency coordination;

reduced administrative costs.

Similarly, a health-data platform may improve:

interoperability;

diagnosis;

appointment coordination;

patient management.

Competition analysis should therefore distinguish legitimate efficiency-producing integration from exclusionary conduct.

31. Key Case-Law Principles

32. Indian Healthcare Competition Analysis

For an Indian competition-law assessment, the following factors are particularly important:

Market structure

number of hospitals;

ownership concentration;

geographic distribution.

Infrastructure

specialist facilities;

diagnostic infrastructure;

emergency infrastructure.

Bargaining power

insurers;

hospital chains;

pharmaceutical companies;

medical-device suppliers.

Digitalization

online healthcare platforms;

digital pharmacies;

telemedicine;

health-data systems.

Entry barriers

capital;

licensing;

accreditation;

specialist availability;

land;

technology.

Competitive effects

price;

quality;

innovation;

access;

choice.

33. Policy Challenges

Health infrastructure competition policy must reconcile several objectives.

Competition

Prevent exclusion and concentration that harms competitive markets.

Healthcare access

Ensure that competition remedies do not unintentionally reduce availability.

Quality

Avoid treating low prices as the only measure of competitive performance.

Innovation

Preserve incentives for medical and technological investment.

Privacy

Protect sensitive health information.

Public interest

Account for legitimate healthcare regulation without allowing public-interest arguments to become a blanket justification for anticompetitive conduct.

34. Practical Competition-Policy Model

A health infrastructure competition investigation can follow this model:

1. Identify infrastructure

What facility, network or platform is involved?

↓

2. Define the relevant market

What products/services and geographic areas compete?

↓

3. Measure market power

Consider shares, barriers, alternatives and buyer power.

↓

4. Identify conduct

Merger, exclusivity, tying, refusal, discrimination, information exchange, etc.

↓

5. Examine foreclosure

Are competitors prevented from accessing patients, suppliers, doctors, data or infrastructure?

↓

6. Assess efficiencies

Does the arrangement improve quality, capacity, investment or efficiency?

↓

7. Assess consumer/patient effects

Consider price, quality, choice, access and innovation.

↓

8. Select proportionate remedy

Possible remedies include:

behavioural commitments;

access obligations;

interoperability;

non-discrimination;

divestiture;

prohibition of particular contractual provisions.

35. Conclusion

Health infrastructure competition policy is increasingly important because modern healthcare is becoming more concentrated, vertically integrated and digitally interconnected.

The principal competition concerns include:

hospital concentration;

hospital mergers;

buyer/monopsony power;

physician-market concentration;

exclusive provider networks;

diagnostic-laboratory concentration;

medical-device tying;

pharmaceutical distribution restrictions;

digital health-platform dominance;

health-data concentration;

interoperability restrictions;

self-preferencing;

ambulance and emergency infrastructure control;

public healthcare procurement; and

vertical integration between insurers, hospitals, pharmacies and digital platforms.

The case law demonstrates that competition policy must examine market power, access, interoperability, foreclosure, discrimination, efficiencies and consumer effects together. Bronner establishes a demanding approach to compulsory infrastructure access; IMS Health illustrates the intersection between intellectual property, data and competition; Microsoft and Slovak Telekom demonstrate the importance of interoperability and infrastructure foreclosure; while United Brands and MEO provide broader principles concerning market power and discriminatory conditions.

For India, Sections 3 and 4 of the Competition Act, 2002 provide the principal substantive framework, while merger-control provisions under Sections 5 and 6 become important as healthcare consolidation accelerates. The long-term policy challenge is to ensure that investment and integration in healthcare infrastructure generate genuine efficiencies without allowing control over essential hospitals, data, technology, distribution or digital networks to become a mechanism for excluding competitors.